isoxazoles has been researched along with Testicular Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andò, S; Barone, I; Bonofiglio, D; Bossi, G; Catalano, S; Giordano, C; Lanzino, M; Malivindi, R; Mauro, L; Panza, S; Sirianni, R; Sisci, D | 1 |
1 other study(ies) available for isoxazoles and Testicular Neoplasms
| Article | Year |
|---|---|
Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aromatase; Cell Proliferation; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Electrophoretic Mobility Shift Assay; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Immunoblotting; Immunoprecipitation; In Situ Nick-End Labeling; Isoxazoles; Leydig Cell Tumor; Male; Mice; Mice, Nude; NF-kappa B; p21-Activated Kinases; Random Allocation; Real-Time Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Testicular Neoplasms; Transcriptional Activation; Tumor Suppressor Protein p53; Up-Regulation; Xenograft Model Antitumor Assays | 2013 |